Pharmacological management of post-traumatic stress disorder : Clinical summary of a five-year retrospective study, 1990-1995

Beginning in 1990, the Department of Psychiatry. Tripler Army Medical Center developed a formal treatment program for post-traumatic stress disorder (PTSD). Between 1990 and 1996, 632 patients, the vast majority of whom suffered from combat-related PTSD, were treated. Historically, many PTSD patient...

Full description

Saved in:
Bibliographic Details
Published in:Military medicine 1997-09, Vol.162 (9), p.616-619
Main Authors: VIOLA, J, DITZLER, T, BATZER, W, HARAZIN, J, ADAMS, D, LETTICH, L, BERIGAN, T
Format: Article
Language:English
Subjects:
Adrenergic alpha-Antagonists - therapeutic use
Anticonvulsants - therapeutic use
Biological and medical sciences
Clonidine - therapeutic use
Humans
Medical sciences
Military Personnel
Neuropharmacology
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Retrospective Studies
Serotonin Uptake Inhibitors - therapeutic use
Stress Disorders, Post-Traumatic - drug therapy
United States
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Beginning in 1990, the Department of Psychiatry. Tripler Army Medical Center developed a formal treatment program for post-traumatic stress disorder (PTSD). Between 1990 and 1996, 632 patients, the vast majority of whom suffered from combat-related PTSD, were treated. Historically, many PTSD patients were treated with benzodiazepines, often in high dosages. The risks attendant to benzodiazepine management of PTSD, coupled with poor clinical outcome, prompted the staff to explore treatment alternatives. This paper describes the role of pharmacotherapy in the management of PTSD. The medications described in this paper have other primary uses in clinical practice (e.g., hypertension, insomnia, seizure control, depression, and anxiety). Medications were selected for use based on the putative modes of action and the degree of symptom relief. The therapeutic rationale was to decrease hyperarousal and sleep disturbance to permit the patients to engage in other psychotherapeutic efforts.
ISSN:0026-4075
1930-613X
DOI:10.1093/milmed/162.9.616